Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study tests a new medicine called SYH2053, given as a shot under the skin, to see if it safely lowers 'bad' LDL cholesterol in people with high cholesterol or mixed lipid problems. About 760 adults whose cholesterol is not at goal will receive either the drug or a placebo. T…

This study compares a new version of a long-acting schizophrenia medication (paliperidone injection given every 3 months) to the approved drug Invega Trinza. About 260 Chinese adults with stable schizophrenia will receive multiple doses to see if the new formulation works similar…

This early-stage trial tests a new injection called SYH2070 in 48 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor side effects and blood fat levels. No treatment benefit is expected; the…